medigraphic.com
ISSN 1561-3054 (Electronic)

2022, Number 3

<< Back Next >>

Rev Cubana Med Trop 2022; 74 (3)

Variation of antimicrobial susceptibility in clinical isolates of Klebsiella pneumoniae and Escherichia coli in inpatients

Cabrera RLE, Miralles SAI, Ones RR, Torres-Herrera Y, Pantaleón HM

Language: Spanish
References: 33
Page:
PDF size: 300.87 Kb.


ABSTRACT

Introduction: The presence of multidrug resistant enterobacteria in hospitals is increasingly frequent.
Objectives: To describe the variation of the antimicrobial susceptibility pattern of Klebsiella pneumoniae and Escherichia coli isolates obtained from clinical samples of patients who were hospitalized and to identify the frequency of multidrug resistant isolates.
Methods: A retrospective and descriptive study was performed between January 1, 2018 and December 31, 2021. The antimicrobial susceptibility was analyzed using the Bauer- Kirby disc diffusion method of 220 isolates (111 K. pneumoniae and 109 E. coli) obtained from clinical samples (blood, skin lesions, vascular catheters and tracheobronchial and surgical wound secretions) of patients hospitalized at the Hospital teaching surgical - clinic Aleida Fernández Chardiet, located in the province of Mayabeque, Cuba.
Results: In the K. pneumoniae isolates during the four years of the study, resistance showed a tendency to increase over time, for all antibiotic tested, except for amoxicillin / ácid clavulánic, which showed a tendency to decrease from 3.34. The percentage difference of the resistance between the year 2021 in relation to 2018 were greater for meropenem, chloramphenicol and amikacin (108.3%, 70,2% y 70.2% respectively). Even so, the data provided evidence that showed statistical significance for the antibiotics cefepime, aztreonam y meropenem (p ≤ 0,05). Regarding the E. coli isolates, resistance showed a tendency to decrease over the course of the four years of the study in eight of the investigated antibiotics. chloramphenicol and amikacin showed an increasing trend of 3.65 y 4.83 respectively. The percentage difference between the extreme years of the study in nine antimicrobials showed values lower than 50.0%. The data provide elements to suggest the presence of statistical significance (p ≤ 0.05) for cefotaxim y ampicilin/sulbactam. Finally, 83.87% of K. pneumoniae isolates and 80.73% of E. coli isolates were multidrug resistant.
Conclusions: There was variation in the susceptibility to antibiotic in the K. pneumoniae and E. coli isolates during the four years of the study. In addition, a high prevalence of multiresistant isolates was observed.


REFERENCES

  1. Martin A, Fahrbach K, Zhao Q, Lodise T. Association between carbapenems resistance and mortality among adult, hospitalized patients with serious infections Due to Enterobacteriaceae: Results of a systematic literature review and meta-analysis. Open Forum Infect Dis. 2018;5(7):ofy150. DOI: https://doi.org/10.1093/ofid/ofy1501.

  2. Antequera A, Sáez C, Ciudad M, García MJ, Moyano B, Rodríguez P, et al. Epidemiología, tratamiento y mortalidad en pacientes infectados por enterobacterias productoras de carbapenemasas: estudio retrospectivo. Rev Chilena Infectol. 2020;37(3):295-303.

  3. Saavedra C, López V, Linares P, Romero P, Solórzano C, Mora J, et al. Prevalencia de factores de riesgo para infección por Klebsiella pneumoniae resistente a carbapenémicos en adultos en un hospital de cuarto nivel, Bogotá D.C. Rev Cuarzo. 2018;24(2):13-9.

  4. Moreno-Rovira LY, Tamayo-Quintero MT, Amariles-Tamayo N, Garrido-Zea EF. Infecciones por Enterobacter y Enterococcus resistentes asociadas a la atención en salud en Hispanoamérica 2002-2017. Medicina & Laboratorio. 2020;24(3):221-32.

  5. Lipari F, Hernández D, Vilaró M, Caeiro J, Saka H. Caracterización clínica, epidemiológica y microbiológica de bacteriemias producidas por enterobacterias resistentes a carbapenems en un hospital universitario de Córdoba, Argentina. Rev Chilena Infectol. 2020;37(4):362-70.

  6. Pacheco R, Osorio L. Prevalencia de bacterias Gram negativas portadoras del gen bla KPC en hospitales de Colombia. Biomédica. 2014;34(1):81-90.

  7. Echeverri-Toro LM, Rueda ZV, Maya W, Agudelo Y, Ospina S. Klebsiella pneumoniae multi-resistente, factores predisponentes y mortalidad asociada en un hospital universitario en Colombia. Rev Chilena Infectol. 2012;29(2):175-82.

  8. Tumbarello M, Sali M, Trecarichi EM, Leone F, Rossi M, Fiori B, et al. Bloodstream Infections Caused by Extended-Spectrum-ß-Lactamase Producing Escherichia coli: Risk Factors for Inadequate Initial Antimicrobial Therapy. Antimicrob Agents Chemother. 2008;52(9):3244-52. DOI: https://doi.org/10.1128/AAC.00063-088.

  9. Wang S, Zhao S, Xiao S, Gu F, Liu Q, Tang J, et al. Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli causing bloodstream infections in three hospitals in Shanghai, China. PLoS One. 2016;11(1):e0147740. DOI: https://doi.org/10.1371/journal.pone.01477409.

  10. Falconí-Sarmiento A, Nolasco-Mejia M, Bedoya-Rozas A, Amaro-Giraldo C, Málaga G. Frecuencia y factores de riesgo para bacteriemia por enterobacterias productoras de BLEE en pacientes de un hospital público de Lima, Perú. Rev Peru Med Exp Salud Pública. 2018;35(1):62-7. DOI: https://doi.org/10.17843/rpmesp.2018.351.360110.

  11. Espinosa-Rivera F, Hart-Casares M, Halley-Posada MC, Zamora-Marín R. Control multidisciplinario de la infección nosocomial en un hospital de nivel terciario. Rev Cubana Med. 2011;50(1):40-8.

  12. Monté-Cerero L, Martínez-Casanueva R. Microorganismos aislados en pacientes ingresados. Hospital "Salvador Allende", La Habana. Febrero a junio de 2015. Rev Haban Cienc Méd. 2017;16(4):552-63.

  13. Quiñones-Pérez D, Carmona-Cartaya Y, Rivero-Rivero M, Pereda-Novales N, Zallas-Illas A, Marrero-Carralero D, et al. Escherichia coli multidrogorresistente en Cuba: emergencia del clon pandémico ST 131. Convención Internacional de Salud. La Habana: Cuba Salud; 2018 [acceso 10/07/2021]. Disponible en: http://www.convencionsalud2018.sld.cu/index.php/connvencionsalud/2018/paper/download/1909/687

  14. Quiñones-Perez D, Betancourt-González Y, Carmona-Cartaya Y, Pereda-Novales N, Álvarez-Valdivia S, Meiji Soe A, et al. Escherichia coli extraintestinal, resistencia antimicrobiana y producción de betalactamasas en aislados cubanos. Rev Cubana Med Trop. 2020;72(3):e605.

  15. Monté-Cepero L, Martínez-Casanueva R. Escherichia coli y Klebsiella pneumoniae productoras de betalactamasas de espectro extendido en un hospital de La Habana. Rev Cubana Hig Epidemiol. 2021;58:e412.

  16. Koneman E, Allen S, Dowell VR, Sommers H. Diagnóstico microbiológico. Buenos Aires: Editorial Medica Panamericana; 2006.

  17. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Test; 26th informational supplement. Wayne: CLSI; 2018.

  18. Jiménez Pearson MA, Galas M, Corso A, Hormazábal JC, Duarte Valderrama C, Salgado Marcano N, et al. Consenso latinoamericano para definir, categorizar y notificar patógenos multirresistentes, con resistencia extendida o panresistentes. Rev Panam Salud Pública. 2019;43:e65. DOI: https://doi.org/10.26633/RPSP.2019.6518.

  19. World Medical Association (WMA). WMA Declaration of Helsinki - Ethical principles for medical research involving human subjects. Fortaleza: 64th WMA General Assembly; 2013.

  20. Azim NSA, Nofal MY, AlHarbi MA, Al-Zaban MI, Somily AM. Molecular diversity, prevalence and antibiotic susceptibility of pathogenic Klebsiella pneumoniae under Saudi condition. Pak J Biol Sci. 2019;22(4):174-9. DOI: https://doi.org/10.3923/pjbs.2019.174.17920.

  21. Tekeli A, Dolapci I, Evren E, Oguzman E, Karahan ZE. Characterization of Klebsiella pneumoniae coproducing KPC and NDM-1 carbapenemases from Turkey. Drug Resist. 2020;26(2):118-25. DOI: https://doi.org/10.1089/mdr.2019.008621.

  22. Quiñones-Pérez D, Carmona-Cartaya Y, Zayas-Illas A, Abreu-Capote M, Salazar-Rodriguez D, García-Giro S, et al. Resistencia antimicrobiana en aislamientos clínicos de Klebsiella spp. y producción de ß-lactamasas de espectro extendido en hospitales de Cuba. Rev Cubana Med Trop. 2014;66(3):386-99.

  23. Suárez-Trueba B, Bustamante-Pérez Y, Hart-Casares M, Romero- García M, González-Maestrey A, Martínez-Batista ML. Caracterización de aislamientos intrahospitalarios de Klebsiella pneumoniae en un hospital terciario. Rev Cub Med. 2015;54(4):323-36.

  24. Miranda-Novales MG, Flores-Moreno K, López-Vidal Y, Rodríguez-Álvarez M, Solórzano-Santos F, Soto-Hernández JL. Antimicrobial resistance and antibiotic consumption in Mexican hospitals. Salud Pública Mex. 2020;62(1):42-9. DOI: https://doi.org/10.21149/1054324.

  25. Khairy RMM, Shokry Mahmoud M, Raouf Shady R, Monem Esmail MA. Multidrug-resistant Klebsiella pneumoniae in hospital-acquired infections: Concomitant analysis of antimicrobial resistant strains. Int J Clin Pract. 2020;74(4):e13463. DOI: https://doi.org/10.1111/ijcp.1346325.

  26. Castro-Jara M, Vieira-Frediani A, Knepper-Zehetmeyer F, Pascoti- Bruhn FR, Ribeiro-Müller M, Giusti-Miller R, et al. Multidrug-resistant hospital bacteria: Epidemiological factors and susceptibility profile. Microb Drug Resist. 2021;27(3):433-40. DOI: https://doi.org/10.1089/mdr.2019.020926.

  27. Zurita-Altamirano I, Morales-Carrasco A, Solmayra-Agreda OI, Ochoa-Crespo D, Gallegos-Paredes M, Rodríguez-Vela V, et al. Infección por bacterias multirresistentes en pacientes con trauma cráneo encefálico del servicio de terapia intensiva del hospital Luis Vernaza, Ecuador. AVFT-Arch Venez Farmacol Ter. 2020;39(6):721-4.

  28. Espinoza-Chávez CE, Cando-Brito VM, Acosta-Acosta LS. Resistencia antimicrobiana de enterobacterias y uso de antibióticos en pacientes de uci clínica Dame 2014. Pol Con. 2020;5(4):271-87. DOI: https://doi.org/10.23857/pc.v5i4.137928.

  29. Zhong Y, Zhang X, Liu W, Yang F, Yan Q, Liu Q, et al. Bloodstream infections with Escherichia coli O16-ST131 and O25b-ST131: molecular epidemiology, phylogenetic analysis and antimicrobial resistance. Nan Fang Yi Ke Da Xue Xue Bao. 2018;38(12):1521-6. DOI: https://doi.org/10.12122/j.issn.1673-4254.2018.12.2029.

  30. Hojabri Z, Mirmoham Madkhani M, Darabi N, Arab M, Pajand O. Characterization of antibiotic-susceptibility patterns and virulence genes of five major sequence types of Escherichia coli isolates cultured from extraintestinal specimens: a 1-year surveillance study from Iran. Infect Drug Resist. 2019;(12):893-903. DOI: https://doi.org/10.2147/IDR.S19975930.

  31. González-Mesa L, González-Leyva M, Zayas-Tamayo AM, Curbelo-Álvarez M, Garrido-Nicot Y. Relación genética de aislados clínicos de Escherichia coli productores de Beta-Lactamasas de Espectro Extendido (BLEE) en un hospital de La Habana, Cuba. Rev CENIC Ciencias Biológicas. 2017;48(3):107-11.

  32. Mazumder R, Abdullah A, Ahmed D, Hussain A. High prevalence of blaCTX-M-15 gene among Extended-Spectrum ß-Lactamase-Producing Escherichia coli isolates causing extraintestinal Infections in Bangladesh. Antibiotics (Basel). 2020;9(11):796. DOI: https://doi.org/10.3390/antibiotics911079632.

  33. Rohit A, Deekshit VK, Balaraj M, Alandur VS, Abraham G, Karunasagar I, et al. CTX-M type extended-spectrum ß-lactamase in Escherichia coli isolated from extra-intestinal infections in a tertiary care hospital in south India. Indian J Med Res. 2019;149(2):281-4. DOI: https://doi.org/10.4103/ijmr.IJMR_2099_1733.




2020     |     www.medigraphic.com